Novo-Nordisk A/S (NVO) is a publicly traded Healthcare sector company. As of May 20, 2026, NVO trades at $44.93 with a market cap of $196.24B and a P/E ratio of 0.00. NVO moved +1.77% today. Year to date, NVO is -15.48%; over the trailing twelve months it is -33.93%. Its 52-week range spans $35.12 to $125.62. Analyst consensus is neutral with an average price target of $43.00. Rallies surfaces NVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NVO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $44.93 |
| Market Cap | $196.24B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 1.22% |
| 52-Week High | $125.62 |
| 52-Week Low | $35.12 |
| Volume | 9.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover NVO: 0 strong buy, 1 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $43.00.